Literature DB >> 28539778

Neuro-ophthalmic sarcoidosis.

Robert P Baughman1, Kenneth L Weiss2, Karl C Golnik3.   

Abstract

Neuro-ophthalmic disease occurs in about a third of patients with neurosarcoidosis. Optic nerve involvement is the most common manifestation, but other cranial nerves and the optic chiasm can be involved. However, there are several other common diseases that cause optic neuropathy, including multiple sclerosis. The diagnosis of sarcoidosis can often be made based on the multi-organ nature of the disease and ancillary testing. Most patients with neuro-ophthalmic sarcoidosis require systemic therapy. While corticosteroids are usually the first step in therapy, cytotoxic agents such as methotrexate and azathioprine have been useful as steroid-sparing agents for chronic disease. The monoclonal antibodies directed against tumor necrosis factor have been reported as effective in refractory cases of neuro-ophthalmic disease.

Entities:  

Keywords:  infliximab; methotrexate; multiple sclerosis; optic neuritis; prednisone; sarcoidosis

Year:  2012        PMID: 28539778      PMCID: PMC5436191          DOI: 10.2147/EB.S29401

Source DB:  PubMed          Journal:  Eye Brain        ISSN: 1179-2744


  97 in total

1.  Adalimumab-associated multiple sclerosis.

Authors:  Lamiae Bensouda-Grimaldi; Denis Mulleman; Jean-Pierre Valat; Elisabeth Autret-Leca
Journal:  J Rheumatol       Date:  2007-01       Impact factor: 4.666

2.  Neuromyelitis optica treatment: analysis of 36 patients.

Authors:  Denis Bernardi Bichuetti; Enedina Maria Lobato de Oliveira; Daniel May Oliveira; Nilton Amorin de Souza; Alberto Alain Gabbai
Journal:  Arch Neurol       Date:  2010-09

3.  The Blau syndrome gene is not a major risk factor for sarcoidosis.

Authors:  B A Rybicki; M J Maliarik; C H Bock; R C Elston; R P Baughman; A P Kimani; R G Sheffer; K M Chen; M Major; J Popovich; M C Iannuzzi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1999-09       Impact factor: 0.670

Review 4.  Review: role of genetics in susceptibility and outcome of sarcoidosis.

Authors:  Johan Grunewald
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

5.  Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial.

Authors:  S L Morgan; J E Baggott; W H Vaughn; J S Austin; T A Veitch; J Y Lee; W J Koopman; C L Krumdieck; G S Alarcón
Journal:  Ann Intern Med       Date:  1994-12-01       Impact factor: 25.391

6.  Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.

Authors:  G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

7.  Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients.

Authors:  Shigemitsu Ninomiya; Takashi Niimi; Shigeki Shimizu; Shigeki Sato; Hiroyuki Achiwa; Hidemi Ito; Kenji Akita; Hiroyoshi Maeda; Ryuzo Ueda
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2004-03       Impact factor: 0.670

8.  Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.

Authors:  Pooja Bhat; Rene A Cervantes-Castañeda; Priyanka P Doctor; Fahd Anzaar; C Stephen Foster
Journal:  Ocul Immunol Inflamm       Date:  2009 May-Jun       Impact factor: 3.070

9.  Sarcoidosis of the anterior visual pathway: successes and failures.

Authors:  M J Gelwan; R I Kellen; R M Burde; M J Kupersmith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

10.  Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis.

Authors:  R J Erckens; R L M Mostard; P A H M Wijnen; J S Schouten; M Drent
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-27       Impact factor: 3.117

View more
  5 in total

1.  An Unusual Presentation of Neurosarcoidosis.

Authors:  Erdal Sarac; Sergul A Erzurum; Ali Arif
Journal:  Am J Case Rep       Date:  2022-09-27

2.  Optic nerve head sarcoidosis mimicking an intraocular tumour, and occurring as the first manifestation of neuro-ocular sarcoidosis.

Authors:  Yamini Krishna; Louise Christou; Jakub Khzouz; Rumana Hussain; Heinrich Heimann; Sarah E Coupland
Journal:  Am J Ophthalmol Case Rep       Date:  2020-10-29

Review 3.  Treatment options for atypical optic neuritis.

Authors:  Amina Malik; Maryam Ahmed; Karl Golnik
Journal:  Indian J Ophthalmol       Date:  2014-10       Impact factor: 1.848

4.  Subretinal peripapillary biopsy-proven sarcoidosis: a case report.

Authors:  Jason R Daley; Svetlana Cherepanoff; Peter G Heydon; Adrian T Fung
Journal:  Int J Retina Vitreous       Date:  2022-09-03

5.  Neurosarcoidosis presenting as CRVO combined CRAO: a biopsy-proven case report of a Chinese patient.

Authors:  Chaoyi Feng; Qian Chen; Wei Liu; Yingwen Bi; Jiang Qian; Min Wang; Xinghuai Sun; Guohong Tian
Journal:  BMC Ophthalmol       Date:  2020-08-27       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.